Johnson Financial Group Inc. Has $77,000 Stock Holdings in McKesson Corporation $MCK

Johnson Financial Group Inc. lowered its stake in McKesson Corporation (NYSE:MCK) by 67.7% during the second quarter, Holdings Channel reports. The institutional investor owned 105 shares of the company’s stock after selling 220 shares during the period. Johnson Financial Group Inc.’s holdings in McKesson were worth $77,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of MCK. Solstein Capital LLC boosted its holdings in shares of McKesson by 171.4% during the second quarter. Solstein Capital LLC now owns 38 shares of the company’s stock worth $28,000 after acquiring an additional 24 shares during the period. Bank of Jackson Hole Trust lifted its holdings in McKesson by 64.3% during the 1st quarter. Bank of Jackson Hole Trust now owns 46 shares of the company’s stock worth $29,000 after purchasing an additional 18 shares during the last quarter. GFG Capital LLC bought a new stake in McKesson in the 2nd quarter valued at $30,000. Saudi Central Bank bought a new stake in McKesson in the 1st quarter valued at $34,000. Finally, Flaharty Asset Management LLC acquired a new position in McKesson in the 1st quarter valued at $39,000. 85.07% of the stock is owned by institutional investors.

McKesson Trading Down 0.5%

MCK opened at $879.00 on Friday. The company’s 50 day moving average is $807.11 and its 200-day moving average is $741.23. McKesson Corporation has a 1-year low of $558.13 and a 1-year high of $895.58. The company has a market cap of $108.49 billion, a P/E ratio of 35.05, a PEG ratio of 1.46 and a beta of 0.51.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, November 5th. The company reported $9.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $8.84 by $1.02. McKesson had a net margin of 0.84% and a negative return on equity of 196.66%. The business had revenue of $103.15 billion during the quarter, compared to analysts’ expectations of $103.80 billion. During the same period in the prior year, the company earned $7.07 EPS. The firm’s quarterly revenue was up 10.2% compared to the same quarter last year. On average, equities analysts forecast that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Stockholders of record on Monday, December 1st will be paid a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Monday, December 1st. McKesson’s dividend payout ratio is presently 10.21%.

Analyst Upgrades and Downgrades

MCK has been the subject of a number of research reports. Zacks Research downgraded McKesson from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 25th. Cowen reaffirmed a “buy” rating on shares of McKesson in a research report on Wednesday, September 24th. Weiss Ratings reiterated a “buy (a-)” rating on shares of McKesson in a research note on Tuesday. Evercore ISI restated an “outperform” rating and set a $1,000.00 target price on shares of McKesson in a research report on Thursday, November 6th. Finally, Mizuho raised their target price on shares of McKesson from $750.00 to $770.00 and gave the stock a “neutral” rating in a report on Wednesday, September 24th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $887.69.

Insider Buying and Selling at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the firm’s stock in a transaction on Friday, November 7th. The stock was sold at an average price of $861.63, for a total transaction of $283,476.27. Following the sale, the chief accounting officer owned 328 shares of the company’s stock, valued at $282,614.64. This trade represents a 50.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.08% of the stock is currently owned by company insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.